Literature DB >> 28393586

Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.

Sara Yazdanpanah1, Mohammad Rabiee1, Mohammadreza Tahriri1,2,3, Mojgan Abdolrahim1, Asadollah Rajab4, Hossein E Jazayeri2, Lobat Tayebi2.   

Abstract

Diabetes Mellitus (DM) is a group of metabolic diseases characterized by chronic high blood glucose concentrations (hyperglycemia). When it is left untreated or improperly managed, it can lead to acute complications including diabetic ketoacidosis and non-ketotic hyperosmolar coma. In addition, possible long-term complications include impotence, nerve damage, stroke, chronic kidney failure, cardiovascular disease, foot ulcers, and retinopathy. Historically, universal methods to measure glycemic control for the diagnosis of diabetes included fasting plasma glucose level (FPG), 2-h plasma glucose (2HP), and random plasma glucose. However, these measurements did not provide information about glycemic control over a long period of time. To address this problem, there has been a switch in the past decade to diagnosing diabetes and its severity through measurement of blood glycated proteins such as Hemoglobin A1c (HbA1c) and glycated albumin (GA). Diagnosis and evaluation of diabetes using glycated proteins has many advantages including high accuracy of glycemic control over a period of time. Currently, common laboratory methods used to measure glycated proteins are high-performance liquid chromatography (HPLC), immunoassay, and electrophoresis. HbA1c is one of the most important diagnostic factors for diabetes. However, some reports indicate that HbA1c is not a suitable marker to determine glycemic control in all diabetic patients. GA, which is not influenced by changes in the lifespan of erythrocytes, is thought to be a good alternative indicator of glycemic control in diabetic patients. Here, we review the literature that has investigated the suitability of HbA1c, GA and GA:HbA1c as indicators of long-term glycemic control and demonstrate the importance of selecting the appropriate glycated protein based on the patient's health status in order to provide useful and modern point-of-care monitoring and treatment.

Entities:  

Keywords:  GA:HbA1c; Glycated hemoglobin; diabetes; diagnosis; glycated albumin; glycemic control

Mesh:

Substances:

Year:  2017        PMID: 28393586     DOI: 10.1080/10408363.2017.1299684

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  28 in total

Review 1.  Effects of Propolis Extract and Propolis-Derived Compounds on Obesity and Diabetes: Knowledge from Cellular and Animal Models.

Authors:  Hiroshi Kitamura
Journal:  Molecules       Date:  2019-12-01       Impact factor: 4.411

2.  Blood Levels of Glycated Hemoglobin, D-Dimer, and Fibrinogen in Diabetic Retinopathy.

Authors:  Heng Zhao; Li-Dan Zhang; Li-Fang Liu; Chun-Qing Li; Wei-Li Song; Yong-Yang Pang; Yun-Liang Zhang; Dan Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-02       Impact factor: 3.168

3.  Improved Functional Causal Likelihood-Based Causal Discovery Method for Diabetes Risk Factors.

Authors:  Xiue Gao; Wenxue Xie; Zumin Wang; Bo Chen; Shengbin Zhou
Journal:  Comput Math Methods Med       Date:  2021-05-14       Impact factor: 2.238

4.  Derivation and Validation of a Prediction Model for Predicting the 5-Year Incidence of Type 2 Diabetes in Non-Obese Adults: A Population-Based Cohort Study.

Authors:  Xin-Tian Cai; Li-Wei Ji; Sha-Sha Liu; Meng-Ru Wang; Mulalibieke Heizhati; Nan-Fang Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-11       Impact factor: 3.168

5.  The association between glycosylated haemoglobin and newly diagnosed hypertension in a non-diabetic Sudanese population: a cross-sectional study.

Authors:  Saeed M Omar; Imad R Musa; Omer Abdelbagi; Manal E Sharif; Ishag Adam
Journal:  BMC Cardiovasc Disord       Date:  2022-05-10       Impact factor: 2.174

6.  Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation.

Authors:  Elena Dozio; Valentina Corradi; Elena Vianello; Elisa Scalzotto; Massimo de Cal; Massimiliano Marco Corsi Romanelli; Claudio Ronco
Journal:  Mediators Inflamm       Date:  2017-09-25       Impact factor: 4.711

7.  The association between skin auto-fluorescence of palmoplantar sites and microvascular complications in Asian patients with type 2 diabetes mellitus.

Authors:  Jong Jin Kim; Bosu Jeong; Yongin Cho; Mi-Hyang Kwon; Yong-Ho Lee; Uk Kang; Eun Seok Kang
Journal:  Sci Rep       Date:  2018-04-20       Impact factor: 4.379

8.  Low HbA1c With Normal Hemoglobin in a Diabetes Patient Caused by PIEZO1 Gene Variant: A Case Report.

Authors:  An Song; Lin Lu; Yuxiu Li; Mei Lin; Xingxing Yuan; Xinqi Cheng; Weibo Xia; Ou Wang; Xiaoping Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-19       Impact factor: 5.555

9.  Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease.

Authors:  Namki Hong; Minyoung Lee; Soyoung Park; Yong-Ho Lee; Sang-Man Jin; Jae Hyeon Kim; Byung-Wan Lee
Journal:  Sci Rep       Date:  2018-04-30       Impact factor: 4.379

10.  Stress Hyperglycemia and Outcome of Non-diabetic Patients After Acute Ischemic Stroke.

Authors:  Bihong Zhu; Yuesong Pan; Jing Jing; Xia Meng; Xingquan Zhao; Liping Liu; Yilong Wang; Yongjun Wang; Zhimin Wang
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.